Introduction
At least 250,000 Americans currently suffer from spinal cord injury (SCI), and each year 10,000 new cases occur in the U.S.A. (NSCIA, 2006) . Many of these individuals will require lifetime care due to motor deficits suffered as a result of the injury. Spasticity is prevalent in both humans and animals following SCI and can contribute to significant functional limitations affecting the ability of a patient to transfer between surfaces and in the case of an incomplete injury, regain locomotion [1] .
At the same time, some individuals with SCI report benefits of spasticity with a need for improved management rather than complete suppression of all motor control that often occurs with current management techniques [1, 2] . This mini-review describes a number of preclinical and clinical studies that promise to improve outcomes, especially in terms of spasticity and hyper-reflexia, in patients with SCI.
One of the major components of spasticity is hyper-reflexia [3] that develops over time following SCI [4] [5] [6] . While the pathophysiology of hyper-reflexia is not completely defined, numerous components have been identified [5, 7] . The components that have been identified to contribute to the development of hyper-reflexia include decreased pre-synaptic inhibition of Ia afferents [8] [9] [10] [11] [12] , upregulation of postsynaptic receptors [5] , terminal sprouting [5] changes in intrinsic properties of motor neurons [13] [14] [15] [16] and recently, changes in gap junctions between spinal cord neurons [17, 18] (see Figure 1) . One measure used to quantify hyper-reflexia is the electrical analogue of the classic tendon jerk reflex, the Hoffman or H-reflex [11, [19] [20] [21] [22] [23] . The H-reflex is a compound electromyographic (EMG) response that can be recorded from the muscle following activation of motor neurons via muscle afferents that are stimulated by applying an electrical current to the nerve (see Figure 1) . The H-reflex is rate sensitive in spinally-intact individuals and demonstrates depressed amplitude, due to marked habituation, once stimulus frequencies reach or exceed 1 Hz [24, 25] . In humans or animals with chronic SCI, frequency dependent depression (FDD) of the H-reflex is markedly less evident [6, 8, 24, 26] .
Spasticity is classically defined as resistance to passive limb movement in proportion to the velocity of movement [27] . This velocitydependent resistance is thought to be due to increased stretch reflex (SR) responses in the lengthened muscle [28] [29] [30] , although increased stiffness in limb compliance is also a factor [31, 32] . The noninvasive measurement of SR using electromyography (EMG) and torque response to a movement perturbation has been reported in the human [33, 34] . Thompson et al developed a device to quantify the SR in rats and documented the velocity dependent response in normal rats [35] , and in rats with a contusion injury of the spinal cord [36] .
However, the SR response in a transection (Tx) injury has not been reported, and evidence TherapeuTIc approaches for spInal cord Injury Induced spasTIcITy abstract Spasticity is evident in both humans and animals following spinal cord injury (SCI) and can contribute to significant functional limitation and disruption in quality of life of patients with this disorder. This mini-review describes a number of preclinical and clinical studies that promise to improve outcomes for, especially in terms of spasticity and hyper-reflexia, patients with SCI. A gold standard for the quantification of spasticity has proved elusive, but the combination of H-reflex frequency dependent depression and a novel stretch reflex (SR) windup protocol have the potential to provide new insights. As the pathophysiology of hyper-reflexia and spasticity continue to be investigated, the documented onset in the animal model of SCI provides critical time points for further study into these complex mechanisms. The positive effects of a passive exercise protocol and several potential pharmacological interventions are reviewed as well as a novel potential mechanism of action. Further work is needed to determine additional mechanisms that are involved in SCI, and how to optimize multiple therapies to overcome some of the deficits induced by SCI.
from human studies indicates that SR responses differ based on completeness of injury [37, 38] .
From a methodological standpoint, single session quantification of the EMG response to imposed stretch is possible, but longitudinal comparison of EMG responses in rodents is problematic because of the inability to normalize the EMG signal. Validity of nonnormalized comparisons can be compromised because measured differences could be due to altered electrode location or spacing rather than a true treatment effect [39] .
One paradigm that overcomes this limitation is the study of the windup of repeated stretches. In a windup protocol, the EMG response to the first stretch is used to normalize subsequent responses. Windup behavior is characterized by temporal facilitation that results in increased amplitude and duration of the reflex responses. This has been demonstrated for flexor reflexes [40] , and more recently in SRs in humans post SCI [41] . It has been suggested that the mechanism for this prolonged SR response is due to alterations in intrinsic motoneuron properties, namely persistent inward currents (PICs). In reduced preparations, PICs demonstrate the ability to amplify and prolong the response to brief inputs [42, 43] , and their emergence is linked to the onset of hyper-reflexia [16, 44] . A stimulus delivered to the popliteal fossa (large black oval, stimulating electrode) first produces an orthodromic (descending dark blue pathway) volley recorded over the soleus muscle (small black circle, recording electrode), as the initial motor (M wave) response. The same stimulus will activate ascending Ia fibers (green pathway) antidromically that results in a monosynaptic connection with the motoneuron (MN), inducing a response that descends (dark blue pathway), and is recorded over the soleus muscle in the human as the longer latency H-reflex (H reflex). Mechanisms that have been proposed to contribute to spasticity include a) loss of presynaptic inhibition of group Ia and II afferent (red pathway) fibers due to loss of descending inhibition from descending tracts (DT, light blue pathway), b) intrinsic changes of the motoneurons, c) upregulation of postsynaptic receptors, and d) terminal sprouting. The present results also suggest that changes in electrical coupling in the area of the interneurons (IN, medium blue pathway) occur after SCI. Interventions outlined in the text include oral modafinil that might influence changes in electrical coupling at the level of the interneurons and motoneurons, passive exercise resulting in possible changes to the motoneuron, and L-dopa, which has been suggested to influence the group II afferent pathways.
Onset of Hyper-reflexia Following SCI
The timing of the onset of hyper-reflexia following SCI has been investigated in both animals and humans [6, 18, 26, 45] . SchindlerIvens and Shields [6] Recently, we developed a method of testing the H-reflex in rats longitudinally in the same animals using percutaneous electrodes [46] .
This method allows us to perform testing in unanesthetized animals using the same animals repeatedly throughout the course of the study, To confirm this finding, exercise MBET was in rats and in cats [60, 61] , an effect that was blocked by haloperidol [62] . Also in cats, both amphetamine and apomorphine improved the rate of recovery of tactile placing following motor cortex injury [63] . While the recovery rate was accelerated with treatment, the end result, however, was about the same.
In a study of short duration, a single dose of amphetamine or placebo was given to stroke patients followed within 3 hrs by a single physical therapy session. The next day, motor scores were significantly improved in patients receiving amphetamine [64] . Also in a single dose study, L-dopa given to patients with SCI suppressed all muscle reflexes induced by large muscle afferents with the peak reduction occurring at 1 hour [65] . In stroke rehabilitation in human patients over a 6-week period, motor recovery improved significantly beginning at 2 weeks when L-dopa was administered 30 minutes prior to physical therapy [66] . This 
Modafinil
The literature revealed limited studies of modafinil as a treatment for hyper-reflexia or spasticity induced by SCI. Mukai and Costa [67] reported positive effects from modafinil on selfesteem in 2 patients with SCI. Hurst et al [68] described a retrospective study of the use of modafinil in a population of children diagnosed with cerebral palsy. They reported 76% of the patients studied reported decreased spasticity after treatment with modafinil, and showed decreased tone after physical examination.
Hurst and Lajara-Nanson and total RNA extracted. cDNA was made as previously described [85, 86] . Primers and standards were developed specifically to quantify Cx-36 transcripts by real-time qRT-PCR following procedures described previously [87] . qRT-PCR was conducted as previously described [86] . Fluorescence was measured at the end of each cycle during amplification.
A melting-curve cycle was used to monitor specificity of amplification. To further ensure accuracy, each reaction was repeated at least twice. The mean value of the repeat was used for each gene per sample to calculate the ratio between the mean value of the target gene (Cx-36) and the two rat housekeeping genes (Gapdh and Rpl). The results of the regional mRNA expression can be seen in Figure 5A -B.
In contrast to the whole cord data, Cx-36 mRNA expression was significantly decreased compared to control levels at 7 weeks post-Tx.
This might reflect changes in the regulation of mRNA translation so that normal (control) levels of protein are synthesized from less mRNA, i.e. an increase in mRNA translation control.
Translational control of Cx-36 mRNA has been reported after amphetamine withdrawl [88] and after ischemia [89] . 
summary
Our Center has investigated H-reflex FDD as a valuable research outcome measure to quantify hyper-reflexia in the animal model and the human patient. We have modified this technique to also include measuring the H-reflex FDD in the awake animal longitudinally.
We have measured the SR and developed the windup protocol as an outcome measure to quantify the development of spasticity in the Tx rat.
We have investigated several interventions including passive MBET, developed a MBET
for human use, and tested pharmacologic interventions including the use of oral modafinil and L-dopa to determine whether these interventions are useful in both the acute and chronic stages of injury to reduce or normalize hyper-reflexia and spasticity. We are currently investigating the role of gap junctions in the spinalized animal and working to determine the regional differences that exist in Cx-36
mRNA. Further work is needed to determine additional mechanisms that are involved in SCI, and how to optimize multiple therapies to overcome some of the deficits induced by SCI.
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